Publications 2002



(mean impactfactor for the top 5 publications = 12.03)

Beroukas D, Goodfellow R, Hiscock J, Jonsson R, Gordon TP, Waterman SA. Upregulation of M3-muscarinic receptors in labial gland acini in primary Sjögren´s syndrome. Lab Invest 82:203-210, 2002. (IF=3.934)

Beroukas D, Hiscock J, Gannon B, Jonsson R, Gordon TP, Waterman SA. Selective downregulation of aquaporin-1 in salivary glands in primary Sjögren´s syndrome. Lab Invest 82:1547-1552, 2002. (IF=3.934)

Bohnhorst JØ, Bjørgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjögren’s syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol 103:79-88, 2002.

Bolstad AI. Nyere forskning på arv og Sjögrens syndrom. Revmatikeren 5/02:18-19, 2002.

Bolstad AI. DNA mikromatriser - små brikker med store konsekvenser. Nor tannlegeforen Tid 112:890-894, 2002.

Bolstad AI, Jonsson R. Genetic aspects of Sjögren´s syndrome. Arthritis Res 4:353-359, 2002.

Brokstad KA, Eriksson JC, Cox RJ, Tynning T, Olofsson J, Jonsson R, Davidsson Å. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. J Inf Dis 185:878-884, 2002. (IF=4.910)

Brun JG, Madland TM, Gjesdal CB, Bertelsen. Sjögren's syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford). 41:301-304, 2002.

Haga H-J, Jonsson R. Sjögrens syndrom – en orientering for pasienter, pårørende og andre interesserte. Norsk Revmatikerforbund, pp. 1-24, 2002. ISBN: 82-90761-27-9; ISSN: 1503-3791.

Haile Y, Bjune G, Wiker HG. Expression of the mceA, esat-6, and hspX genes in Myocbacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply. Microbiol - SGM 148:3881-3886, 2002.

Haile Y, Caugant DA, Bjune G, Wiker HG. Mycobacterium tuberculosis mammalian cell entry operon (mce) homologs in Mycobacterium other than tuberculosis (MOTT). FEMS Immunol Med Microbiol 33:125-132, 2002.

Johanneson B, Lima G, von Salomé J, Alarcón-Segovia D, The collaborative group on the genetics of SLE, The BIOMED II collaboration on the genetics of SLE and Sjögren´s syndrome, Alarcón-Riquelme ME. A major susceptibility locus for systemic lupus erythematosus maps to chromosome 1q31. Am J Hum Genet 71:1060-1071, 2002.

Johansson ÅCM, Nakken B, Sundler M, Lindquist A-KB, Johannesson M, Alarcón-Riqulme M, Bolstad AI, Humphreys-Beher M, Jonsson R, Skarstein K, Holmdahl R. Genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur J Immunol 32: 243-250, 2002. (IF=4.990)

Jonsson R. Sjögren´s syndrome. In: Classic Papers in Rheumatology, Dieppe P, Wollheim FA, Schumacher HR, eds. London: Martin Dunitz Ltd 2002; pp-202-221.

Jonsson R, Brokstad KA, Hansen T, Davies T, Ulvestad E. The evolution and breakdown of the immune system: implications for development of autoimmune diseases. Scand J Immunol 56: 323-326, 2002.

Jonsson R, Hulten B, Olofsson J. Current concepts and diagnosis of Sjögren´s syndrome. ENT News 11(2): 79-82, 2002.

Jonsson R, Moen K, Vestrheim D, Szodoray P. Current issues in Sjögren´s syndrome. Oral Dis 8: 130-140, 2002.

Jonsson R, Skarstein K. Experimental models of Sjögren's syndrome. In: The Molecular Pathology of Autoimmune Diseases, eds. Theofilopoulos, Bona. 2nd Edit. Taylor & Francis, New York 2002; pp-437-452. ISBN: 90-5702-645-7

Madland TM, Hordvik M, Haga H-J, Jonsson R, Brun JG. Leukocyte calprotectin and outcome in rheumatoid arthritis: a longitudinal study. Scand J Rheumatol 31:351-354, 2002.

Mogga SJ, Mustafa T, Sviland L, Nilsen R. Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol 56:383-391, 2002.

Nakken B. The genetics of Sjögren´s syndrome: Candidate gene analyses and genome-wide linkage studies. Dr thesis, Univ of Bergen. 2002.

Ohlsson M. Apoptosis, autoantigens and autoantibodies in Sjögren´s syndrome. Dr thesis, Univ of Bergen. 2002.

Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: A possible mechanism in the pathogenesis of Sjögren´s syndrome. Scand J Immunol 56: 456-469, 2002.

Ohlsson M, Szodoray P, Lako Loro L, Johannessen AC, Jonsson R. CD40, CD154, bax and bcl-2 expression in Sjögren´s syndrome salivary glands – a putative anti-apoptotic role during its effector phases. Scand J Immunol 56: 561-571, 2002.

Prokunina L, Castillejo-López C, Öberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdottir H, Grøndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönsson A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32: 666-669, 2002. (IF=29.600)

Tran HB, Ohlsson M, Beroukas D, Hiscock J, Bradley J, Buyon J, Gordon TP. Subcellular redistribution of La (SS-B) autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block. Arthritis Rheum 45: 202-208, 2002. (IF=7.389)

Tzioufas AG, Wassmuth R, Dafni UG, Guiallis A, Haga HJ, Isenberg DA, Jonsson R, Kalden J, Kiener H, Sakarellos C, Smolen JS, Sutcliffe N, Vitali C, Yiannaki E, Moutsopoulos HM. Clinical, immunological and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren´s syndrome: A European multicentre study. Ann Rheum Dis 61:398-404, 2002.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, and the European Study Group on Classsification Criteria for Sjögren´s syndrome. Classification criteria for Sjögren´s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 61:554-558, 2002.

Waterman SA, Beroukas D, Hiscock J, Gordon TP, Jonsson R. Distribution of salivary aquaporin-5 in Sjögren´s syndrome (letter). Lancet 359:1778, 2002. (IF=3.251)